MARKER THERAPEUTICS, INC. Partners' Capital Account, Private Placement of Units
MARKER THERAPEUTICS, INC. (MRKR) reported Partners' Capital Account, Private Placement of Units of $2.33 million for the 9-month period ending 2015-09-30, per its 10-Q/A filed 2016-04-14.
Discontinued › Partners' Capital
us-gaap:PartnersCapitalAccountPrivatePlacementOfUnits · last filed 2016-04-14
- 2015-09-30: Partners' Capital Account, Private Placement of Units 9 month $2.33M; Partners' Capital Account, Private Placement of Units 9 month as first filed -$2.01M.
- 2014-09-30: Partners' Capital Account, Private Placement of Units 9 month $2.10M; Partners' Capital Account, Private Placement of Units 9 month as first filed -$2.10M.
| Period end | Partners' Capital Account, Private Placement of Units 9 month | Partners' Capital Account, Private Placement of Units 9 month as first filed |
|---|---|---|
| 2015-09-30 | $2.33M 10-Q/A · filed 2016-04-14 | -$2.01M 10-Q · filed 2015-11-16 |
| 2014-09-30 | $2.10M 10-Q/A · filed 2016-04-14 | -$2.10M 10-Q · filed 2015-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |